TBRG

TBRG
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $86.106M ▲ | $39.99M ▼ | $5.602M ▲ | 6.506% ▲ | $0.37 ▲ | $14.538M ▲ |
| Q2-2025 | $85.729M ▼ | $40.832M ▲ | $2.58M ▲ | 3.009% ▲ | $0.17 ▲ | $10.365M ▼ |
| Q1-2025 | $87.208M ▼ | $39.535M ▼ | $459K ▲ | 0.526% ▲ | $0.031 ▲ | $14.719M ▲ |
| Q4-2024 | $90.84M ▲ | $40.612M ▲ | $-3.065M ▲ | -3.374% ▲ | $-0.39 ▼ | $14.096M ▲ |
| Q3-2024 | $83.83M | $39.517M | $-9.809M | -11.701% | $0.45 | $8.03M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $19.92K ▼ | $399.412K ▼ | $219.054K ▼ | $180.358K ▼ |
| Q2-2025 | $12.279M ▲ | $390.151M ▲ | $216.978M ▼ | $173.173M ▲ |
| Q1-2025 | $10.124M ▼ | $388.842M ▼ | $220.334M ▼ | $168.508M ▼ |
| Q4-2024 | $12.324M ▲ | $394.432M ▼ | $225.737M ▼ | $168.695M ▼ |
| Q3-2024 | $8.586M | $401.533M | $228.886M | $172.647M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.602M ▲ | $13.59M ▲ | $-3.987M ▲ | $-1.962M ▼ | $7.641M ▲ | $13.653M ▲ |
| Q2-2025 | $2.58M ▲ | $8.757M ▲ | $-4.727M ▼ | $-1.875M ▲ | $2.155M ▲ | $8.213M ▲ |
| Q1-2025 | $459K ▲ | $5.76M ▼ | $-2.232M ▼ | $-5.728M ▼ | $-2.2M ▼ | $1.426M ▼ |
| Q4-2024 | $-3.065M ▲ | $10.296M ▲ | $-1.682M ▲ | $-4.876M ▼ | $3.738M ▲ | $6.139M ▲ |
| Q3-2024 | $-11.132M | $10.109M | $-5.313M | $-3.919M | $877K | $4.796M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
TruBridge is a niche healthcare technology and services provider with stable but slow revenue growth and uneven profitability. Its balance sheet is serviceable but not overly conservative, with rising debt and limited cash that leave less room for prolonged setbacks. Cash flow is generally positive but modest, which can support ongoing operations and gradual improvement but may constrain larger strategic moves without better earnings. Competitively, the company benefits from deep expertise in rural and community healthcare, a sticky integrated product suite, and flexible revenue cycle solutions, but it operates in a crowded and evolving market and serves financially stressed customers. On the innovation front, TruBridge appears active and forward‑leaning, especially in AI, automation, and creative commercial models. The key question going forward is whether these strategic and technological strengths can translate into more consistent profits and a stronger financial cushion over time.
NEWS
November 6, 2025 · 4:05 PM UTC
TruBridge Announces Third Quarter 2025 Results
Read more
October 31, 2025 · 11:00 AM UTC
TruBridge Announces Third Quarter 2025 Conference Call to Be Held Friday, November 7, 2025
Read more
October 3, 2025 · 9:15 AM UTC
TruBridge Names Michael Daughton as Chief Business Officer to Advance Mission of Strengthening Rural and Community Healthcare
Read more
September 23, 2025 · 9:00 AM UTC
Java Medical Group Expands Partnership With TruBridge for EHR, Financial Health Technology, and Services
Read more
About TruBridge, Inc.
https://www.trubridge.comTruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $86.106M ▲ | $39.99M ▼ | $5.602M ▲ | 6.506% ▲ | $0.37 ▲ | $14.538M ▲ |
| Q2-2025 | $85.729M ▼ | $40.832M ▲ | $2.58M ▲ | 3.009% ▲ | $0.17 ▲ | $10.365M ▼ |
| Q1-2025 | $87.208M ▼ | $39.535M ▼ | $459K ▲ | 0.526% ▲ | $0.031 ▲ | $14.719M ▲ |
| Q4-2024 | $90.84M ▲ | $40.612M ▲ | $-3.065M ▲ | -3.374% ▲ | $-0.39 ▼ | $14.096M ▲ |
| Q3-2024 | $83.83M | $39.517M | $-9.809M | -11.701% | $0.45 | $8.03M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $19.92K ▼ | $399.412K ▼ | $219.054K ▼ | $180.358K ▼ |
| Q2-2025 | $12.279M ▲ | $390.151M ▲ | $216.978M ▼ | $173.173M ▲ |
| Q1-2025 | $10.124M ▼ | $388.842M ▼ | $220.334M ▼ | $168.508M ▼ |
| Q4-2024 | $12.324M ▲ | $394.432M ▼ | $225.737M ▼ | $168.695M ▼ |
| Q3-2024 | $8.586M | $401.533M | $228.886M | $172.647M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.602M ▲ | $13.59M ▲ | $-3.987M ▲ | $-1.962M ▼ | $7.641M ▲ | $13.653M ▲ |
| Q2-2025 | $2.58M ▲ | $8.757M ▲ | $-4.727M ▼ | $-1.875M ▲ | $2.155M ▲ | $8.213M ▲ |
| Q1-2025 | $459K ▲ | $5.76M ▼ | $-2.232M ▼ | $-5.728M ▼ | $-2.2M ▼ | $1.426M ▼ |
| Q4-2024 | $-3.065M ▲ | $10.296M ▲ | $-1.682M ▲ | $-4.876M ▼ | $3.738M ▲ | $6.139M ▲ |
| Q3-2024 | $-11.132M | $10.109M | $-5.313M | $-3.919M | $877K | $4.796M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
TruBridge is a niche healthcare technology and services provider with stable but slow revenue growth and uneven profitability. Its balance sheet is serviceable but not overly conservative, with rising debt and limited cash that leave less room for prolonged setbacks. Cash flow is generally positive but modest, which can support ongoing operations and gradual improvement but may constrain larger strategic moves without better earnings. Competitively, the company benefits from deep expertise in rural and community healthcare, a sticky integrated product suite, and flexible revenue cycle solutions, but it operates in a crowded and evolving market and serves financially stressed customers. On the innovation front, TruBridge appears active and forward‑leaning, especially in AI, automation, and creative commercial models. The key question going forward is whether these strategic and technological strengths can translate into more consistent profits and a stronger financial cushion over time.
NEWS
November 6, 2025 · 4:05 PM UTC
TruBridge Announces Third Quarter 2025 Results
Read more
October 31, 2025 · 11:00 AM UTC
TruBridge Announces Third Quarter 2025 Conference Call to Be Held Friday, November 7, 2025
Read more
October 3, 2025 · 9:15 AM UTC
TruBridge Names Michael Daughton as Chief Business Officer to Advance Mission of Strengthening Rural and Community Healthcare
Read more
September 23, 2025 · 9:00 AM UTC
Java Medical Group Expands Partnership With TruBridge for EHR, Financial Health Technology, and Services
Read more

CEO
Christopher L. Fowler
Compensation Summary
(Year 2024)

CEO
Christopher L. Fowler
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

BLACKROCK, INC.
777.761K Shares
$17.08M

VANGUARD GROUP INC
755.373K Shares
$16.588M

NELLORE CAPITAL MANAGEMENT LLC
747.032K Shares
$16.405M

DIMENSIONAL FUND ADVISORS LP
470.593K Shares
$10.334M

MARTIN & CO INC /TN/
425.009K Shares
$9.333M

AMERIPRISE FINANCIAL INC
289.035K Shares
$6.347M

FEDERATED HERMES, INC.
283.232K Shares
$6.22M

KENNEDY CAPITAL MANAGEMENT LLC
276.94K Shares
$6.082M

BLACKROCK INC.
274.542K Shares
$6.029M

GEODE CAPITAL MANAGEMENT, LLC
255.777K Shares
$5.617M

ACADIAN ASSET MANAGEMENT LLC
212.063K Shares
$4.657M

MORGAN STANLEY
179.833K Shares
$3.949M

HILLSDALE INVESTMENT MANAGEMENT INC.
168.918K Shares
$3.709M

STATE STREET CORP
162.481K Shares
$3.568M

RENAISSANCE TECHNOLOGIES LLC
149.651K Shares
$3.286M

CITADEL ADVISORS LLC
136.256K Shares
$2.992M

TWO SIGMA INVESTMENTS, LP
124.856K Shares
$2.742M

PARADIGM CAPITAL MANAGEMENT INC/NY
122.856K Shares
$2.698M

D. E. SHAW & CO., INC.
111.631K Shares
$2.451M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
107.18K Shares
$2.354M
Summary
Only Showing The Top 20



